PCD Pharma Franchise Opportunities in Tamil Nadu with Daksh Diabetes and Cardiac Care
Recent health data reveals that Tamil Nadu has become a hotspot for India’s diabetes epidemic, with the prevalence of the disease more than doubling over the past decade. According to an ICMR–INDIAB study, the prevalence of diabetes in people over the age of 20 in Tamil Nadu was 11.1% between 2008 and 2010, which increased to 22.7% in 2022–2023, representing a 104% increase. Meanwhile, the prevalence of prediabetes rose from 12.2% to a staggering 24.8%, a 103% increase. This means there are about 12 million people who already have diabetes in the state, and another 10 million who will develop it in the next few years unless serious steps are taken.
The epidemic is not merely an urban phenomenon. Rates of diabetes in rural Tamil Nadu rose from 8.3% to 18.3% during the same period, representing a 120% increase rural prevalence is rising even faster than in urban areas. A state-wide STEPS survey conducted by the ICMR-National Institute of Epidemiology found that the overall prevalence of hypertension in Tamil Nadu is 33.9% and that of diabetes is 17.6% among adults aged 18-69. The survey also found that 28.5% of the population is overweight and 11.4% is obese. Non-communicable diseases account for nearly 75% of all deaths in Tamil Nadu.
The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Tamil Nadu families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes.
How Daksh is making a Difference in Tamil Nadu
1. Affordable, Quality-Assured Medications
Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment.
What this means for Tamil Nadu patients:
- Access to WHO-GMP certified medications
- Lower out-of-pocket expenses for lifelong treatments
- No compromise on quality despite affordable pricing
2. Complete Cardiac Care Portfolio
Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs:
| Product Category | Daksh Offerings | Purpose |
| ACE Inhibitors | DORAPIL (Ramipril) | Blood pressure control, heart failure treatment |
| ARBs | CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) | Hypertension management |
| Beta-Blockers | CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) | Heart rate control, heart failure |
| Calcium Channel Blockers | DUPIN (Amlodipine), CLINITAC (Cilnidipine) | Blood pressure, angina |
| Diuretics | TORDAC (Torsemide), FRUSIDIP | Fluid management in heart failure |
| Lipid Management | ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) | Cholesterol control |
3. Complete Diabetic Care Portfolio
For diabetes management, Daksh provides modern therapeutic options including:
| Product Category | Daksh Offerings |
| SGLT2 Inhibitors | DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug |
| DPP-4 Inhibitors | TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) |
| Sulfonylureas | GLIMIDAC (Glimepiride) |
| Biguanides | GLYCODIP SR (Metformin) |
| Combination Therapies | DYFOZIN M, GLIMIDAC MV (triple combination) |
4. Focus on Preventive Care
Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications:
- Liver tonics for medication-induced liver protection
- Calcium supplements for bone health (critical for diabetic patients)
- Vitamin complexes for overall metabolic support
5. Supporting Healthcare Providers across Tamil Nadu
Daksh works with hospitals, clinics, and pharmacies across Tamil Nadu to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses.
With the state’s high disease burden and growing pharmaceutical sector, there is immense potential to build a meaningful healthcare business while serving your community.
Popular Locations for PCD Pharma Franchise in Tamil Nadu
| PCD / Franchise Keywords | Product / Therapy Keywords |
| PCD pharma franchise in Chennai | Cardiac diabetic PCD company in Chennai |
| PCD pharma franchise in Coimbatore | Cardiac diabetic products in Coimbatore |
| PCD pharma franchise in Madurai | Diabetic cardiac PCD franchise in Madurai |
| PCD pharma franchise in Trichy | Cardiac diabetic PCD company in Trichy |
| PCD pharma franchise in Salem | Cardiac diabetic products in Salem |
| PCD pharma franchise in Tirunelveli | Diabetic cardiac PCD franchise in Tirunelveli |
| PCD pharma franchise in Vellore | Cardiac diabetic PCD company in Vellore |
| PCD pharma franchise in Erode | Cardiac diabetic products in Erode |
| PCD pharma franchise in Thanjavur | Diabetic cardiac PCD franchise in Thanjavur |
| PCD pharma franchise in Kanyakumari | Cardiac diabetic PCD company in Kanyakumari |
Conclusion
The diabetes and heart disease epidemic in Tamil Nadu is not just a statistic—it is a reality affecting millions of families. With the state recording a 22.7% diabetes prevalence (a 104% increase over a decade), a rural diabetes prevalence of 18.3% (a 120% increase), and hypertension affecting 33.9%, the burden is already immense and growing. But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives.
Daksh Diabetic & Cardiac Care is committed to being part of this solution—providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines.
Contact Daksh Diabetic and Cardiac
| Contact Method | Details |
| Office Address | Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India |
| Phone | 📞 +91 93565 60523 📞 +91 78886 02869 |
| enquirypurchase.daksh@gmail.com | |
| Contact us | https://diabetes-cardiac.com/contact-us/ |